Startups
1-10 Employees
smartiBONEsmartiBONEsmartiBONE: Engineering the Future of Blood Stem Cell Therapies
We are addressing one of the greatest bottlenecks in regenerative medicine: delivering functional blood stem cells on demand for life-saving therapies, whenever and wherever patients need them.
In partnership with Ludwig-Maximilians-Universität (LMU) Munich, smartiBONE has secured Phase 2 (Machbarkeitsphase) funding through the BMBF’s GO-Bio initial program.
By 2028, our goal is to deliver a robust proof-of-concept for the scalable, de novo manufacturing of functional hematopoietic stem cells.
Partner with Us!
Whether you are exploring joint R&D, strategic collaboration, or early-stage investment, we would love to connect.
We are addressing one of the greatest bottlenecks in regenerative medicine: delivering functional blood stem cells on demand for life-saving therapies, whenever and wherever patients need them.
In partnership with Ludwig-Maximilians-Universität (LMU) Munich, smartiBONE has secured Phase 2 (Machbarkeitsphase) funding through the BMBF’s GO-Bio initial program.
By 2028, our goal is to deliver a robust proof-of-concept for the scalable, de novo manufacturing of functional hematopoietic stem cells.
Partner with Us!
Whether you are exploring joint R&D, strategic collaboration, or early-stage investment, we would love to connect.
Address
Carl-Neuberg-Straße 1, 30625 Hannover, Germany
Finance Data
| Date | Investors | Amount | Stage |
Financial Overview
No revenue recorded yet